These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

375 related items for PubMed ID: 7705213

  • 21. Effect of oral pilocarpine on post-irradiation xerostomia in head and neck cancer patients: a single-center, single-blind clinical trial.
    Chitapanarux I, Kamnerdsupaphon P, Tharavichitkul E, Sumitsawan Y, Sittitrai P, Pattarasakulchai T, Lorvidhaya V, Sukthomya V, Pukanhaphan N, Traisatit P.
    J Med Assoc Thai; 2008 Sep; 91(9):1410-5. PubMed ID: 18843872
    [Abstract] [Full Text] [Related]

  • 22. Pilocarpine treatment of xerostomia in head and neck patients.
    Leek H, Albertsson M.
    Micron; 2002 Sep; 33(2):153-5. PubMed ID: 11567884
    [Abstract] [Full Text] [Related]

  • 23. Efficacy of pilocarpine lozenge for post-radiation xerostomia in patients with head and neck cancer.
    Taweechaisupapong S, Pesee M, Aromdee C, Laopaiboon M, Khunkitti W.
    Aust Dent J; 2006 Dec; 51(4):333-7. PubMed ID: 17256309
    [Abstract] [Full Text] [Related]

  • 24.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 25.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 26.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 27. A randomized study to assess the effectiveness of orally administered pilocarpine during and after radiotherapy of head and neck cancer.
    Nyárády Z, Németh A, Bán A, Mukics A, Nyárády J, Ember I, Olasz L.
    Anticancer Res; 2006 Dec; 26(2B):1557-62. PubMed ID: 16619571
    [Abstract] [Full Text] [Related]

  • 28.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 29. Does salivary gland scintigraphy predict response to pilocarpine in patients with post-radiotherapy xerostomia?
    Cooper RA, Cowan RA, Owens SE, Jeans SP, Roberts JK, Hillel PG, Slevin NJ, Allan E, Gupta NK, Collins CD.
    Eur J Nucl Med; 1999 Mar; 26(3):220-5. PubMed ID: 10079311
    [Abstract] [Full Text] [Related]

  • 30. Effect of pilocarpine during radiation therapy: results of RTOG 97-09, a phase III randomized study in head and neck cancer patients.
    Scarantino C, LeVeque F, Swann RS, White R, Schulsinger A, Hodson DI, Meredith R, Foote R, Brachman D, Lee N.
    J Support Oncol; 2006 May; 4(5):252-8. PubMed ID: 16724649
    [Abstract] [Full Text] [Related]

  • 31. Buccal drug delivery technologies for patient-centred treatment of radiation-induced xerostomia (dry mouth).
    Malallah OS, Garcia CMA, Proctor GB, Forbes B, Royall PG.
    Int J Pharm; 2018 Apr 25; 541(1-2):157-166. PubMed ID: 29425763
    [Abstract] [Full Text] [Related]

  • 32. Post-radiation severe xerostomia relieved by pilocarpine: a prospective French cooperative study.
    Horiot JC, Lipinski F, Schraub S, Maulard-Durdux C, Bensadoun RJ, Ardiet JM, Bolla M, Coscas Y, Baillet F, Coche-Dequéant B, Urbajtel M, Montbarbon X, Bourdin S, Wibault M, Alfonsi M, Calais G, Desprez P, Pene F, Lapeyre M, Vinke J, Maral J.
    Radiother Oncol; 2000 Jun 25; 55(3):233-9. PubMed ID: 11041775
    [Abstract] [Full Text] [Related]

  • 33.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 34. Protection of salivary function by concomitant pilocarpine during radiotherapy: a double-blind, randomized, placebo-controlled study.
    Burlage FR, Roesink JM, Kampinga HH, Coppes RP, Terhaard C, Langendijk JA, van Luijk P, Stokman MA, Vissink A.
    Int J Radiat Oncol Biol Phys; 2008 Jan 01; 70(1):14-22. PubMed ID: 17869018
    [Abstract] [Full Text] [Related]

  • 35. Oral pilocarpine (Salagen)--a recently approved salivary stimulant.
    Wynn RL.
    Gen Dent; 1996 Jan 01; 44(1):26, 29-30. PubMed ID: 8940567
    [No Abstract] [Full Text] [Related]

  • 36. Phase III randomized study: oral pilocarpine versus submandibular salivary gland transfer protocol for the management of radiation-induced xerostomia.
    Jha N, Seikaly H, Harris J, Williams D, Sultanem K, Hier M, Ghosh S, Black M, Butler J, Sutherland D, Kerr P, Barnaby P.
    Head Neck; 2009 Feb 01; 31(2):234-43. PubMed ID: 19107948
    [Abstract] [Full Text] [Related]

  • 37. [Usefulness of pilocarpine in the prevention of xerostomia in patients with head and neck cancer treated with radiotherapy. Assessment with gammagraphy and salivary flow].
    Fuertes Cabero S, Setoain Perego X, Rovirosa Casino A, Mateos Fernández JJ, Fuster Pelfort D, Ferre Jorge J, Navalpotro Yagüe V, Paredes Barranco P, Ortín Pérez J, Muxí Pradas A, Pons Pons F.
    Rev Esp Med Nucl; 2004 Feb 01; 23(4):259-66. PubMed ID: 15207210
    [Abstract] [Full Text] [Related]

  • 38. Pilocarpine disposition and salivary flow responses following intravenous administration to dogs.
    Weaver ML, Tanzer JM, Kramer PA.
    Pharm Res; 1992 Aug 01; 9(8):1064-9. PubMed ID: 1409379
    [Abstract] [Full Text] [Related]

  • 39. Transdermal pilocarpine on the skin over salivary glands to increase salivation: an in vivo study.
    Ishida N, Katsura A, Takagaki K, Arakawa H, Shimada T, Mizuno S, Sai Y, Kato Y, Nakamura H, Suga Y, Matsushita R.
    BMC Oral Health; 2024 Aug 02; 24(1):881. PubMed ID: 39095752
    [Abstract] [Full Text] [Related]

  • 40. Acquired salivary dysfunction. Drugs and radiation.
    Fox PC.
    Ann N Y Acad Sci; 1998 Apr 15; 842():132-7. PubMed ID: 9599303
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 19.